| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 12 1277-1286, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
E Berezutskaya, B Yu, A Morozov, P Raychaudhuri and S Bagchi
Center for Molecular Biology of Oral Diseases, College of Dentistry 60612, USA.
The human papillomavirus E7 oncoprotein binds to the retinoblastoma (Rb) tumor suppressor protein, and the binding to Rb correlates with the oncogenic potential of E7. Recent studies from several laboratories indicated that the half-life of the Rb protein is reduced in cells that are stably transformed with E7, suggesting that E7 could induce the proteolytic degradation of Rb. To investigate whether the Rb degradation is a primary effect of E7 or a result of altered cell phenotype, we sought to develop assays that can distinguish between the two possibilities. Using recombinant adenovirus expressing the human papillomavirus type 16 E7 protein, we show that the expression of E7 leads to an increased rate of decay of the Rb protein. Moreover, Rb degradation immediately follows the expression of E7 suggesting that it is an early and primary effect. Consistent with a previous study, we observed that the E7-induced degradation of Rb can be blocked by the inhibitors of the 26S proteasome. We have also developed a transient transfection assay for the E7-induced degradation of Rb. Using this assay, we show that the pocket domain of Rb is necessary and sufficient for the E7-induced degradation. However, the proteolysis is relatively specific for Rb because the level of p107 or p130 was not significantly altered by the expression of E7. Thus, although E7 binds to all three members of the Rb family of proteins, the proteolysis is much more efficient in the case of Rb. In the transient transfection assays, adenovirus E1A and SV40 large T antigen failed to induce degradation of Rb, suggesting that the Rb degradation is a unique property of the E7 oncoprotein.
This article has been cited by other articles:
![]() |
K. Huh, X. Zhou, H. Hayakawa, J.-Y. Cho, T. A. Libermann, J. Jin, J. Wade Harper, and K. Munger Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor J. Virol., September 15, 2007; 81(18): 9737 - 9747. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Oh, A. Kalinina, N.-H. Park, and S. Bagchi Deregulation of eIF4E: 4E-BP1 in Differentiated Human Papillomavirus-Containing Cells Leads to High Levels of Expression of the E7 Oncoprotein J. Virol., July 15, 2006; 80(14): 7079 - 7088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Knight, N. Sharma, and E. S. Robertson Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase PNAS, December 20, 2005; 102(51): 18562 - 18566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Munger, A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh Mechanisms of Human Papillomavirus-Induced Oncogenesis J. Virol., November 1, 2004; 78(21): 11451 - 11460. [Full Text] [PDF] |
||||
![]() |
M. S. Longworth and L. A. Laimins Pathogenesis of Human Papillomaviruses in Differentiating Epithelia Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 362 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Oh, A. Kalinina, J. Wang, K. Nakayama, K. I. Nakayama, and S. Bagchi The Papillomavirus E7 Oncoprotein Is Ubiquitinated by UbcH7 and Cullin 1- and Skp2-Containing E3 Ligase J. Virol., May 15, 2004; 78(10): 5338 - 5346. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Psyrri, R. A. DeFilippis, A. P. B. Edwards, K. E. Yates, L. Manuelidis, and D. DiMaio Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells Cancer Res., May 1, 2004; 64(9): 3079 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, Y. Liu, and J. J. Chen Activation of c-Myc Contributes to Bovine Papillomavirus Type 1 E7-induced Cell Proliferation J. Biol. Chem., October 31, 2003; 278(44): 43163 - 43168. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Kalejta, J. T. Bechtel, and T. Shenk Human Cytomegalovirus pp71 Stimulates Cell Cycle Progression by Inducing the Proteasome-Dependent Degradation of the Retinoblastoma Family of Tumor Suppressors Mol. Cell. Biol., March 15, 2003; 23(6): 1885 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. von Willebrand, E. Zacksenhaus, E. Cheng, P. Glazer, and R. Halaban The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells Cancer Res., March 15, 2003; 63(6): 1420 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Helt and D. A. Galloway Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins Carcinogenesis, February 1, 2003; 24(2): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Helt, J. O. Funk, and D. A. Galloway Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells J. Virol., September 11, 2002; 76(20): 10559 - 10568. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Dick and N. J. Dyson Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins J. Virol., May 13, 2002; 76(12): 6224 - 6234. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Chien, F. Noya, H. M. Benedict-Hamilton, T. R. Broker, and L. T. Chow Alternative Fates of Keratinocytes Transduced by Human Papillomavirus Type 18 E7 during Squamous Differentiation J. Virol., February 22, 2002; 76(6): 2964 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gonzalez, M. Stremlau, X. He, J. R. Basile, and K. Munger Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7 J. Virol., August 15, 2001; 75(16): 7583 - 7591. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Helt and D. A. Galloway Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes J. Virol., August 1, 2001; 75(15): 6737 - 6747. [Abstract] [Full Text] |
||||
![]() |
F. Noya, W.-M. Chien, T. R. Broker, and L. T. Chow p21cip1 Degradation in Differentiated Keratinocytes Is Abrogated by Costabilization with Cyclin E Induced by Human Papillomavirus E7 J. Virol., July 1, 2001; 75(13): 6121 - 6134. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Goodwin and D. DiMaio Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways PNAS, November 7, 2000; 97(23): 12513 - 12518. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ouyang, L.-j. Mou, C. Luk, N. Liu, J. Karaskova, J. Squire, and M.-S. Tsao Immortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype Am. J. Pathol., November 1, 2000; 157(5): 1623 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, E. C. Goodwin, L. K. Naeger, E. Vigo, K. Galaktionov, K. Helin, and D. DiMaio E2F-Rb Complexes Assemble and Inhibit cdc25A Transcription in Cervical Carcinoma Cells following Repression of Human Papillomavirus Oncogene Expression Mol. Cell. Biol., October 1, 2000; 20(19): 7059 - 7067. [Abstract] [Full Text] |
||||
![]() |
W.-M. Chien, J. N. Parker, D.-C. Schmidt-Grimminger, T. R. Broker, and L. T. Chow Casein Kinase II Phosphorylation of the Human Papillomavirus-18 E7 Protein Is Critical for Promoting S-Phase Entry Cell Growth Differ., August 1, 2000; 11(8): 425 - 435. [Abstract] [Full Text] |
||||
![]() |
R. A. Levine and M. A. Fleischli Inactivation of p53 and Retinoblastoma Family Pathways in Canine Osteosarcoma Cell Lines Vet. Pathol., January 1, 2000; 37(1): 54 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spancake, C. B. Anderson, V. M. Weaver, N. Matsunami, M. J. Bissell, and R. L. White E7-transduced Human Breast Epithelial Cells Show Partial Differentiation in Three-dimensional Culture Cancer Res., December 1, 1999; 59(24): 6042 - 6045. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Smith-McCune, D. Kalman, C. Robbins, S. Shivakumar, L. Yuschenkoff, and J. M. Bishop Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130 PNAS, June 8, 1999; 96(12): 6999 - 7004. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Hwang, D. Lee, J. Kim, T. Seo, and J. Choe Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner J. Biol. Chem., January 18, 2002; 277(4): 2923 - 2930. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |